Synergistic chemiluminescence enhancement by a MOF-derived Co3O4/In2O3 heterojunction for norepinephrine detection
Analytica Chimica Acta · 2026
DOI: 10.1016/j.aca.2026.345546 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytica Chimica Acta, 2026. Verfasst von Jinwei Xiao und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Electroanalytical Chemistry, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, Jilin, 130022,…. Hauptthemen laut MEDLINE: Norepinephrine, Luminescent Measurements, Cobalt, Oxides. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: Ministry of Science and Technology of the People's Republic of China, Natural Science Foundation of Jilin Province, China Scholarship Council.
Abstract (Originalsprache)
BACKGROUND: The sensitive detection of norepinephrine (NE) is crucial for understanding physiological processes and diagnosing related disorders. Although chemiluminescence (CL) offers advantages such as high sensitivity and simple instrumentation, the luminol/H2O2 system often suffers from low catalytic efficiency. Developing high-performance, low-cost catalysts to enhance CL remains a key challenge. RESULTS: In this work, a hierarchically structured Co3O4/In2O3 p-n heterojunction was constructed via a MOF-on-MOF precursor approach, in which dodecahedral Co3O4 nanoparticles were uniformly anchored onto In2O3 microtubes. Benefiting from the synergistic effect between the Co3+/Co2+ redox centers, abundant oxygen vacancies, and interfacial charge redistribution, the resulting heterostructure exhibits remarkably enhanced catalytic activity toward H2O2 decomposition and enhanced luminol/H2O2 CL by approximately 2500 folds. On this basis, a simple and sensitive flow-injection CL sensing platform was established for the quantitative detection of norepinephrine which effectively quenches the CL emission through competitive consumption of reactive oxygen species. The proposed method displays a wide linear range from 5 to 15000 nM with a low detection limit of 1.24 nM (S/N = 3). Moreover, satisfactory recoveries (97.96-103.59%) were obtained for norepinephrine determination in human serum samples, demonstrating good accuracy and practical applicability. SIGNIFICANCE: This work presents a novel MOF-derived p-n heterojunction strategy to synergistically enhance chemiluminescence through interfacial charge regulation and oxygen vacancy engineering. The strategy provides a robust, ultrasensitive platform for NE detection, highlighting the potential of heterojunction engineering in CL-based bioanalysis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Electroanalytical Chemistry, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, Jilin, 130022, China; School of Applied Chemistry and Engineering, University of Sci…
Förderung
- Ministry of Science and Technology of the People's Republic of China
- Natural Science Foundation of Jilin Province
- China Scholarship Council
- National Natural Science Foundation of China
Zitieren
APA
Xiao, J., Liu, Y., Liu, J., Lijalem, T., Tessema, S. S., Liu, S., Ma, J., & Xu, G. (2026). Synergistic chemiluminescence enhancement by a MOF-derived Co3O4/In2O3 heterojunction for norepinephrine detection. Analytica Chimica Acta. https://doi.org/10.1016/j.aca.2026.345546
Vancouver
Xiao J, Liu Y, Liu J, Lijalem T, Tessema SS, Liu S, et al. Synergistic chemiluminescence enhancement by a MOF-derived Co3O4/In2O3 heterojunction for norepinephrine detection. Analytica Chimica Acta. 2026. doi:10.1016/j.aca.2026.345546
BibTeX
@article{Xiao2026,
author = {Xiao, Jinwei and Liu, Yutong and Liu, Jiyang and Lijalem, Tsegu and Tessema, Solomon Sime and Liu, Shichen and Ma, Jintao and Xu, Guobao},
title = {Synergistic chemiluminescence enhancement by a MOF-derived Co3O4/In2O3 heterojunction for norepinephrine detection},
journal = {Analytica Chimica Acta},
year = {2026},
doi = {10.1016/j.aca.2026.345546}
}
EUVIMED